Injection/Infusion
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
Summary
DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML — Injection/Infusion containing naxitamab. Hong Kong Registration No. HK-68305. Certificate Holder: SCICLONE PHARMACEUTICALS INTERNATIONAL LTD. Date of Registration: 16 Jul, 2024.
Product NameDANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML
Registration No.HK-68305
Certificate HolderSCICLONE PHARMACEUTICALS INTERNATIONAL LTD
Holder AddressUNIT 3, 14/F, CHEUNG FUNG INDUSTRIAL BUILDING, 23-39, PAK TIN PAR STREET, TSUEN WAN, NEW TERRITORIES
Ingredientsnaxitamab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration16 Jul, 2024
ATC codesL01FX21
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。